Dry, dark and at 0-4 °C for short term (days to weeks) or -20 °C for long term (months to years).
Alternative CAS
1443211-72-0 (free base); 1448754-43-5 (HCl)
Biological Target
Eleclazine hydrochloride is a novel late Na+ current inhibitor with IC50 value of 0.7 uM.
Drug Formulation
This drug may be formulated in DMSO
Elemental Analysis
C, 55.82; H, 3.79; Cl, 7.85; F, 12.61; N, 9.30; O, 10.62
Exact Mass
451.0911
HS Tariff Code
2934.99.03.00
In Vitro Activity
TBD
In Vivo Activity
Eleclazine (10 μM) inhibited INa in atrial and ventricular myocytes in a use-dependent manner consistent with preferential activated state block. Eleclazine produced voltage-dependent instantaneous inhibition in atrial and ventricular myocytes; it caused a negative shift in voltage of half-maximal inactivation and slowed the recovery of INa from inactivation in both cell types. Reference: Heart Rhythm O2. 2020 Aug;1(3):206-214. https://pubmed.ncbi.nlm.nih.gov/32864638/
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Stock Solution Storage
0-4 °C for short term (days to weeks), or -20 °C for long term (months).